From pathogenesis to clinical practice: Emerging medical treatments for endometriosis

Sara Clemenza1, Flavia Sorbi1, Ivo Noci1, Tommaso Capezzuoli1, Irene Turrini1, Carlo Carriero1, Nicolò Maria Buffi1, Massimiliano Fambrini1, Felice Petraglia1
1Department of Biomedical, Experimental and Clinical Sciences, Division of Obstetrics and Gynecology, University of Florence, Florence, Italy

Tóm tắt

Từ khóa


Tài liệu tham khảo

Practice Committee of the American Society for Reproductive Medicine, 2014, Treatment of pelvic pain associated with endometriosis: a committee opinion, Fertil Steril, 101, 927, 10.1016/j.fertnstert.2014.02.012

Burney, 2012, Pathogenesis and pathophysiology of endometriosis, Fertil Steril, 98, 511, 10.1016/j.fertnstert.2012.06.029

Tosti, 2017, Hormonal therapy for endometriosis: from molecular research to bedside, Eur J Obstet Gynecol Reprod Biol, 209, 61, 10.1016/j.ejogrb.2016.05.032

Vercellini, 2014, Endometriosis: pathogenesis and treatment, Nat Rev Endocrinol, 10, 261, 10.1038/nrendo.2013.255

Reis, 2013, Endometriosis: hormone regulation and clinical consequences of chemotaxis and apoptosis, Hum Reprod Update, 19, 406, 10.1093/humupd/dmt010

Chwalisz, 2005, Selective progesterone receptor modulator development and use in the treatment of leiomyomata and endometriosis, Endocr Rev, 26, 423, 10.1210/er.2005-0001

Bedaiwy, 2017, New developments in the medical treatment of endometriosis, Fertil Steril, 107, 555, 10.1016/j.fertnstert.2016.12.025

Goenka, 2017, A peek into the drug development scenario of endometriosis - a systematic review, Biomed Pharmacother, 90, 575, 10.1016/j.biopha.2017.03.092

Taylor, 2017, Treatment of endometriosis-associated pain with elagolix, an oral GnRH antagonist, N Engl J Med, 377, 28, 10.1056/NEJMoa1700089

Perricos, 2017, Efficacy of elagolix in the treatment of endometriosis, Expert Opin Pharmacother, 28, 1

Velasco, 2006, Aromatase expression in endometriotic tissues and cell cultures of patients with endometriosis, Mol Hum Reprod, 12, 377, 10.1093/molehr/gal041

Rafique, 2017, Medical management of endometriosis, Clin Obstet Gynecol, 60, 485, 10.1097/GRF.0000000000000292

Nawathe, 2008, Systematic review of the effects of aromatase inhibitors on pain associated with endometriosis, BJOG, 115, 818, 10.1111/j.1471-0528.2008.01740.x

Ferrero, 2009, Letrozole combined with norethisterone acetate compared with norethisterone acetate alone in the treatment of pain symptoms caused by endometriosis, Hum Reprod, 24, 3033, 10.1093/humrep/dep302

2014, ESHRE endometriosis guideline development group management of women with endometriosis, Hum Reprod, 29, 400, 10.1093/humrep/det457

Kulak, 2011, Treatment with bazedoxifene, a selective estrogen receptor modulator, causes regression of endometriosis in a mouse model, Endocrinology, 152, 3226, 10.1210/en.2010-1010

Yao, 2005, Validation of rat endometriosis model by using raloxifene as a positive control for the evaluation of novel SERM compounds, J Invest Surg, 18, 177, 10.1080/08941930591004412

Altintas, 2010, Comparison of the effects of raloxifene and anastrozole on experimental endometriosis, Eur J Obstet Gynecol Reprod Biol, 150, 84, 10.1016/j.ejogrb.2010.02.004

Stratton, 2008, Return of chronic pelvic pain from endometriosis after raloxifene treatment: a randomized controlled trial, Obstet Gynecol, 111, 88, 10.1097/01.AOG.0000297307.35024.b5

Naqvi, 2014, Treatment with ba- zedoxifene and conjugated estrogens results in regression of endometriosis in a murine model, Biol Reprod, 90, 121, 10.1095/biolreprod.113.114165

Rocha, 2012, New trends for the medical treatment of endometriosi, Expert Opin Investig Drugs, 21, 905, 10.1517/13543784.2012.683783

Bouchard, 2011, Selective progesterone receptor modulators in reproductive medicine: pharmacology, clinical efficacy and safety, Fertil Steril, 96, 1175, 10.1016/j.fertnstert.2011.08.021

Kettel, 1996, Treatment of endometriosis with the antiprogesterone mifepristone (RU486), Fertil Steril, 65, 23, 10.1016/S0015-0282(16)58022-4

Kettel, 1998, Preliminary report on the treatment of endometriosis with low-dose mifepristone (RU 486), Am J Obstet Gynecol, 178, 1151, 10.1016/S0002-9378(98)70316-3

Chwalisz, 2004, Treatment of endometriosis with the novel selective progesterone receptor modulator (SPRM) asoprisnil, Fertil Steril, 82, S83, 10.1016/j.fertnstert.2004.07.825

Bruner-Tran, 2006, Down- regulation of endometrial matrix metalloproteinase-3 and -7 expression in vitro and therapeutic regression of experimental endometriosis in vivo by a novel nonsteroidal progesterone receptor agonist, tanaproget, J Clin Endocrinol Metab, 91, 1554, 10.1210/jc.2005-2024

Fu, 2017, Progesterone receptor modulators for endometriosis, Cochrane Database Syst Rev, 25, 7

Marjoribanks, 2015, Nonsteeroidal anti-inflammatory drugs for dysmenorrhoea, Cochrane Database Syst Rev

Chishima, 2002, Increased expression of cyclooxygenase-2 in local lesions of endometriosis patients, Am J Reprod Immunol, 48, 50, 10.1034/j.1600-0897.2002.01101.x

Cobellis, 2004, The treatment with a COX-2 specific inhibitor is effective in the management of pain related to endometriosis, Eur J Obstet Gynecol Reprod Biol, 116, 100, 10.1016/j.ejogrb.2004.02.007

Machado, 2010, A selective cyclooxygenase-2 inhibitor suppresses the growth of endometriosis with an antiangiogenic effect in a rat model, Fertil Steril, 93, 2674, 10.1016/j.fertnstert.2009.11.037

Pall, 2001, Induction of delayed follicular rupture in the human by the selective COX-2 inhibitor rofecoxib: a randomized double-blind study, Hum Reprod, 16, 1323, 10.1093/humrep/16.7.1323

Bata, 2006, Delay of ovulation by meloxicam in healthy cycling volunteers: a placebo-controlled, double-blind, crossover study, J Clin Pharmacol, 46, 925, 10.1177/0091270006289483

Brown, 2017, Nonsteroidal anti-inflammatory drugs for pain in women with endometriosis, Cochrane Database Syst Rev, 1

Braun, 2002, Peritoneal fluid-mediated enhancement of eutopic and ectopic endometrial cell proliferation is dependent on tumor necrosis factor-alpha in women with endometriosis, Fertil Steril, 78, 727, 10.1016/S0015-0282(02)03318-6

Bedaiwy, 2002, Agarwal. Prediction of endometriosis with serum and peritoneal fluid markers: a prospective controlled trial, Hum Reprod, 17, 426, 10.1093/humrep/17.2.426

D'Antonio, 2000, Ability of recombinant human TNF binding protein-1 (r-hTBP-1) to inhibit the development of experimentally-induced endometriosis in rats, J Reprod Immunol, 48, 81, 10.1016/S0165-0378(00)00073-5

Barrier, 2004, Efficacy of anti-tumor necrosis factor therapy in the treatment of spontaneous endometriosis in baboons, Fertil Steril, 81, 775, 10.1016/j.fertnstert.2003.09.034

Falconer, 2006, D'Hooghe TM.Treatment with anti-TNF monoclonal antibody (c5N) reduces the extent of induced endometriosis in the baboon, Hum Reprod, 21, 1856, 10.1093/humrep/del044

Koninckx, 2008, Anti- TNF-a treatment for deep endometriosis-associated pain: a randomized placebo-controlled trial, Hum Reprod, 23, 2017, 10.1093/humrep/den177

Lu, 2013, Anti-TNF-a treatment for pelvic pain associated with endometriosis, Cochrane Database Syst Rev, 10.1002/14651858.CD008088.pub3

Creus, 2008, Combined laparoscopic surgery and pentoxifylline therapy for treatment of endometriosis-associated infertility: a preliminary trial, Hum Reprod, 23, 1910, 10.1093/humrep/den167

Alborzi, 2007, Pentoxifylline therapy after laparoscopic surgery for different stages of endometriosis: a prospective, double-blind, randomized, placebo-controlled study, J Minim Invasive Gynecol, 14, 54, 10.1016/j.jmig.2006.06.024

Lu, 2012, Pentoxifylline for endometriosis, Cochrane Database Syst Rev, 1

Quattrone, 2015, The targeted delivery of interleukin 4 inhibits development of endometriotic lesions in a mouse model, Reprod Sci, 22, 1143, 10.1177/1933719115578930

Somigliana, 1999, Endometrial ability to implant in ectopic sites can be prevented by interleukin-12 in a murine model of endometriosis, Hum Reprod, 14, 2944, 10.1093/humrep/14.12.2944

Ingelmo, 2013, Effect of human interferon-a-2b on experimental endometriosis in rats: comparison between short and long series of treatment, Eur J Obstet Gynecol Reprod Biol, 167, 190, 10.1016/j.ejogrb.2012.11.019

Kumar, 2014, Lipoxin A4 prevents the progression of de novo and established endometriosis in a mouse model by attenuating prostaglandin E2 production and estrogen signaling, PLoS One, 9

Ren, 2016, Effect of rapamycin on endometriosis in mice, Exp Ther Med, 12, 101, 10.3892/etm.2016.3280

Keenan, 1999, Regression of endometrial explants in a rat model of endometriosis treated with the immune modulators loxoribine and levamisole, Fertil Steril, 72, 135, 10.1016/S0015-0282(99)00157-0

Acién, 2002, Use of intraperitoneal interferon α-2b therapy after conservative surgery for endometriosis and postoperative medical treatment with depot gonadotropin-releasing hormone analog: a randomized clinical trial, Fertil Steril, 78, 705, 10.1016/S0015-0282(02)03330-7

Yilmaz, 2010, Atorvastatin causes regression of endometriotic implants in a rat model, Reprod Biomed Online, 20, 291, 10.1016/j.rbmo.2009.11.004

Nasu, 2009, Simvastatin inhibits the proliferation and the contractility of human endometriotic stromal cells: a promising agent for the treatment of endometriosis, Fertil Steril, 92, 2097, 10.1016/j.fertnstert.2009.06.055

Bruner-Tran, 2009, Simvastatin protects against the development of endometriosis in a nude mouse model, J Clin Endocrinol Metab, 94, 2489, 10.1210/jc.2008-2802

Almassinokiani, 2013, Effects of simvastatin in prevention of pain recurrences after surgery for endometriosis, Med Sci Monit., 19, 534, 10.12659/MSM.883967

Rung, 2006, Depletion of substrates for protein prenylation increases apoptosis in human periovulatory granulosa cells, Mol Reprod Dev, 73, 1277, 10.1002/mrd.20551

Rung, 2005, Progesterone-receptor antagonists and statins decrease de novo cholesterol synthesis and increase apoptosis in rat and human periovulatory granulosa cells in vitro, Biol Reprod, 72, 538, 10.1095/biolreprod.104.033878

Ortega, 2012, Simvastatin reduces steroidogenesis by inhibiting Cyp17a1 gene expression in rat ovarian theca-interstitial cells, Biol Reprod, 86, 1, 10.1095/biolreprod.111.094714

Gizzo, 2014, Could empirical low-dose- aspirin administration during IVF cycle affect both the oocytes and embryos quality via COX 1-2 activity inhibition?, J Assist Reprod Genet, 31, 261, 10.1007/s10815-014-0174-7

Vitagliano, 2016, Statins as targeted “magical pills” for the conservative treatment of endometriosis: may potential adverse effects on female fertility represent the “dark side of the same Coin”? A systematic review of literature, Reprod Sci, 23, 415, 10.1177/1933719115584446

Kawano, 2011, Application of the histone deacetylase inhibitors for the treatment of endometriosis: histonemodifications as pathogenesis and novel therapeutic target, Hum Reprod, 26, 2486, 10.1093/humrep/der203

Imesch, 2011, Inhibition of transcription, expression, and secretion of the vascular epithelial growth factor in human epithelial endometriotic cells by romidepsin, Fertil Steril, 95, 1579, 10.1016/j.fertnstert.2010.12.058

Lu, 2010, Trichostatin A, a histone deacetylase inhibitor, reduces lesion growth and hyperalgesia in experimentally induced endometriosis in mice, Hum Reprod, 25, 1014, 10.1093/humrep/dep472

Mmed, 2012, Valproic acid and progestin inhibit lesion growth and reduce hyperalgesia in experimentally induced endometriosis in rats, Reprod Sci, 19, 360, 10.1177/1933719111424453

Osteen, 2002, Paracrine mediators of endometrial matrix metalloproteinase expression: potential targets for progestin-based treatment of endometriosis, Ann N Y Acad Sci, 955, 139, 10.1111/j.1749-6632.2002.tb02774.x

Krikun, 2010, The immunoconjugate ‘‘icon’’ targets aberrantly expressed endothelial tissue factor causing regression of endometriosis, Am J Pathol, 176, 1050, 10.2353/ajpath.2010.090757

Lebovic, 2013, PPARγ activation inhibits growth and survival of human endometriotic cells by suppressing estrogen biosynthesis and PGE2 signaling, Endocrinology, 154, 4803, 10.1210/en.2013-1168

Ohama, 2008, Peroxisome proliferator-activated receptor-γ ligand reduced tumor necrosis factor-α-induced interleukin-8 production and growth in endometriotic stromal cells, Fertil Steril, 89, 311, 10.1016/j.fertnstert.2007.03.061

Lebovic, 2004, Peroxisome proliferator-activated receptor-γ induces regression of endometrial explants in a rat model of endometriosis, Fertil Steril, 82, 1008, 10.1016/j.fertnstert.2004.02.148

Lebovic, 2007, PPAR-γ receptor ligand induces regression of endometrial explants in baboons: a prospective, randomized, placebo- and drug-controlled study, Fertil Steril, 88, 1108, 10.1016/j.fertnstert.2006.12.072

Lebovic, 2010, Peroxisome proliferator-activated receptor-γ receptor ligand partially prevents the development of endometrial explants in baboons: a prospective, randomized, placebo-controlled study, Endocrinology, 151, 1846, 10.1210/en.2009-1076

Herington, 2011, Development and prevention of postsurgical adhesions in a chimeric mouse model of experimental endometriosis, Fertil Steril, 95, 1295, 10.1016/j.fertnstert.2010.09.017

Nenicu, 2014, Combined blockade of angiotensin II type 1 receptor and activation of peroxisome proliferator-activated receptor-γ by telmisartan effectively inhibits vascularization and growth of murine endometriosis-like lesions, Hum Reprod, 29, 1011, 10.1093/humrep/deu035

Novella-Maestre, 2009, Dopamine agonist administration causes a reduction in endometrial implants through modulation of angiogenesis in experimentally induced endometriosis, Hum Reprod, 24, 1025, 10.1093/humrep/den499

Delgado-Rosas, 2011, The effects of ergot and non- ergot-derived dopamine agonists in an experimental mouse model of endometriosis, Reproduction, 142, 745, 10.1530/REP-11-0223

Ercan, 2015, Comparison of efficacy of bromocriptine and cabergoline to GnRH agonist in a rat endometriosis model, Arch Gynecol Obstet, 291, 1103, 10.1007/s00404-014-3524-x

Bouaziz, 2017, The clinical significance of endocannabinoids in endometriosis pain management, Cannabis Cannabinoid Res., 2, 72, 10.1089/can.2016.0035

Sanchez, 2012, The molecular connections between the cannabinoid system and endometriosis, Mol Hum Reprod, 18, 563, 10.1093/molehr/gas037

Leconte, 2010, Antiproliferative effects of cannabinoid agonists on deep infiltrating endometriosis, Am J Pathol, 177, 2963, 10.2353/ajpath.2010.100375

Sanchez, 2017, Panina-Bordignon P6 the cannabinoid receptor CB1 contributes to the development of ectopic lesions in a mouse model of endometriosis, Hum Reprod, 32, 175

Di Blasio, 2013, The endocannabinoid pathway and the female reproductive organs, J Mol Endocrinol, 50, R1, 10.1530/JME-12-0182